Market Tracker

03/16 5:15pm ET

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Mar 16
 -0.4009 / -0.43%
Today’s Change
Today|||52-Week Range
XBI Regular Dividend: XBI began trading ex-dividend on 03/16/18. A $0.0591 dividend will be paid to shareholders of record as of 03/19/18.

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+1.24% 3 years+7.00%
3 months+14.40% 5 years+23.57%
1 year+31.40% Since inception+15.79%
Data through 03/17/2018

Quote Details

Previous close$93.97
Open day’s range93.45 – 94.40
Net asset value (NAV)93.54 (03/16/2018)
Daily volume3,463,842
Average volume (3 months)4,540,586
Data as of 8:00pm ET, 03/16/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+23.57%+17.28%
Expense Gross exp ratio0.35%1.30%
Risk 5 year sharpe ratio0.851.02
Net assets$4.7B$3.1B
Average market cap$3.8B$10.4B
Average P/E--22.9
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 2.89%
ARRY Array Biopharma Inc2.19%
-- 2.11%
LOXO Loxo Oncology Inc1.87%
ABBV AbbVie1.72%
AVXS AveXis Inc1.71%
IMMU Immunomedics Inc1.70%
BLUE bluebird bio Inc1.67%
SRPT Sarepta Therapeutics Inc1.65%
VRTX Vertex Pharmaceuticals Inc1.65%